Cargando…

Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention

BACKGROUND: Conventional risk factors for sudden cardiac death (SCD) justify primary prevention through implantable cardioverter-defibrillator (ICD) implantation in hypertrophic cardiomyopathy (HCM) patients. However, the positive predictive values for these conventional SCD risk factors are low. Le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yazaki, Kyoichiro, Suzuki, Atsushi, Shiga, Tsuyoshi, Minami, Yuichiro, Arai, Kotaro, Ashihara, Kyomi, Shoda, Morio, Hagiwara, Nobuhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893864/ https://www.ncbi.nlm.nih.gov/pubmed/33607967 http://dx.doi.org/10.1186/s12872-021-01910-0

Ejemplares similares

Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure
por: Nomoto, Michiru, et al.
Publicado: (2022)

Left atrial reentrant tachycardia with interatrial dissociation mimicking accelerated idioventricular rhythm in a patient with a cardiac resynchronization defibrillator
por: Yazaki, Kyoichiro, et al.
Publicado: (2021)

Deactivation of implantable cardioverter defibrillator in Japanese patients with end‐stage heart failure
por: Nakazawa, Mayui, et al.
Publicado: (2020)

Stress echocardiography causes stress cardiomyopathy: A very rare complication should be reminded
por: Takagi, Atsushi, et al.
Publicado: (2012)

Impact of fracture‐prone implantable cardioverter defibrillator leads on long‐term patient mortality
por: Koike, Toshiharu, et al.
Publicado: (2023)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Avoidance behavior associated with depressive symptoms in patients with implantable cardioverter defibrillators
por: Ichikura, Kanako, et al.
Publicado: (2017)

Regional differences in the effects of the ablation index and interlesion distance on acute electrical reconnections after pulmonary vein isolation
por: Yazaki, Kyoichiro, et al.
Publicado: (2020)

Transvenous Biopsy of a Primary Cardiac Lymphoma Guided by Real-Time 3-Dimensional Reconstructed Imaging From Intracardiac Echography
por: Nomoto, Michiru, et al.
Publicado: (2021)

Catheter Ablation for Atrial Fibrillation Targeting Incremental Left Ventricular Ejection Fraction　― Reply ―
por: Yazaki, Kyoichiro, et al.
Publicado: (2021)

Prognostic Implication of First‐Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy
por: Higuchi, Satoshi, et al.
Publicado: (2020)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy
por: Minami, Yuichiro, et al.
Publicado: (2018)

Impact of atrial fibrillation ablation on long‐term outcomes in patients with tachycardia‐bradycardia syndrome
por: Kataoka, Shohei, et al.
Publicado: (2022)

Incidence and predictors of early and late sudden cardiac death in hospitalized Japanese patients with new‐onset systolic heart failure
por: Minami, Yoshiaki, et al.
Publicado: (2021)

Comparison of high‐power and conventional‐power radiofrequency energy deliveries in pulmonary vein isolation using unipolar signal modification as a local endpoint
por: Ejima, Koichiro, et al.
Publicado: (2020)

Successful coronary vein lead implantation by intravascular ultrasound guidance in a patient with life-threatening contrast medium anaphylaxis
por: Kataoka, Shohei, et al.
Publicado: (2020)

Acute and Long-Term Outcomes of Transvenous Cardiac Pacing Device Implantation in Patients With Congenital Heart Disease
por: Takeuchi, Daiji, et al.
Publicado: (2019)

Prognostic Significance of Post-Procedural Left Ventricular Ejection Fraction Following Atrial Fibrillation Ablation in Patients With Systolic Dysfunction
por: Yazaki, Kyoichiro, et al.
Publicado: (2020)

Regional differences in the predictors of acute electrical reconnection following high‐power pulmonary vein isolation for paroxysmal atrial fibrillation
por: Yazaki, Kyoichiro, et al.
Publicado: (2021)

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016)

An overlap of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Kataoka, Shohei, et al.
Publicado: (2016)

Transvenous lead extraction in a patient with polysplenia and inferior vena cava defect
por: Kataoka, Shohei, et al.
Publicado: (2020)

Prognostic significance of diastolic dysfunction in patients with systolic dysfunction undergoing atrial fibrillation ablation
por: Koike, Toshiharu, et al.
Publicado: (2022)

Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy
por: Goldstein, Sarah A., et al.
Publicado: (2023)

Transvenous shock‐only implantable cardioverter defibrillator after an atrio‐pulmonary Fontan surgery
por: Toyohara, Keiko, et al.
Publicado: (2020)

Anesthesia in a Child with Newly Diagnosed Hypertrophic Cardiomyopathy for Placement of Implantable Cardioverter Defibrillator
por: Kumar, Rajnish, et al.
Publicado: (2018)

Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
por: Park, Yae Min
Publicado: (2023)

Myopotential oversensing notified by Lead Integrity Alert in a patient with implantable cardioverter defibrillator with a dedicated bipolar epicardial sensing lead
por: Yazaki, Kyoichiro, et al.
Publicado: (2016)

Wearable cardioverter-defibrillator as bridging to ICD in pediatric hypertrophic cardiomyopathy with myocardial bridging – a case report
por: Kurath-Koller, Stefan, et al.
Publicado: (2020)

Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience
por: Matsui, Yuko, et al.
Publicado: (2019)

Changes in the Left Ventricular Ejection Fraction and Outcomes in Hospitalized Heart Failure Patients with Mid-range Ejection Fraction: A Prospective Observational Study
por: Tsukamoto, Kei, et al.
Publicado: (2020)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
por: Malhotra, Rakesh, et al.
Publicado: (2017)

High-Risk Apical Hypertrophic Cardiomyopathy Requiring an Implantable Cardioverter-Defibrillator: A Case Report of an Overlooked Etiology
por: Rathore, Azeem, et al.
Publicado: (2023)

Obstetric hemorrhage in a case of hypertrophic obstructive cardiomyopathy with automatic implantable cardioverter defibrillator: Anaesthesia and intensive care management
por: Mishra, Sandeep Kumar, et al.
Publicado: (2016)

Atrial fibrillation deteriorates tricuspid regurgitation following implantable cardioverter defibrillator lead placement in patient with hypertrophic obstructive cardiomyopathy
por: Mohri, Takato, et al.
Publicado: (2017)

Progressive electrical remodeling in apical hypertrophic cardiomyopathy leading to implantable cardioverter-defibrillator sensing failure during ventricular fibrillation
por: Fleeman, Blake E., et al.
Publicado: (2016)

Natural language processing of implantable cardioverter-defibrillator reports in hypertrophic cardiomyopathy: A paradigm for longitudinal device follow-up
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_575v2818l6uh7jtokgjsk6adj1